LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Stocks making the biggest moves premarket: Moderna, Kohl’s, Intuit, Analog Devices & more

Garry Wills by Garry Wills
May 24, 2023
in Business Finance
Stocks making the biggest moves premarket: Moderna, Kohl’s, Intuit, Analog Devices & more
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

People walk near a Kohl’s department store entranceway on June 07, 2022 in Doral, Florida.

Joe Raedle | Getty Images

Check out the companies making headlines in premarket trading Wednesday

Moderna — The biotech company added 2.4% amid renewed Covid-19 concern in China after an uptick in infections.

V.F. Corporation — Shares in the clothing and shoemaker added 3.3% on the back of better-than-expected fiscal fourth-quarter results. The company earned an adjusted 17 cents per share, topping a Refinitiv forecast of 14 cents per share. Revenue of $2.74 billion was also slightly above expectations.

XPeng — The electric vehicle maker slipped 4.7% after an earnings miss. XPeng also issued weaker-than-expected revenue guidance for the second quarter. Still, CEO He Xiaopeng said he is “confident in taking our Company into a virtuous cycle driving product sales growth, team morale, customer satisfaction and brand reputation over the next few quarters.”

Palantir Technologies — Shares were 2.2% lower in premarket trading, on pace for their first decline in three sessions. Cathie Wood’s Ark Invest recently bought more than $4 million worth of Palantir shares, the firm’s website showed.

Analog Devices — Analog Devices dropped 5.3% in premarket trading on the back of weaker-than-expected third-quarter guidance for the fiscal third quarter. Analog Devices expects adjusted earnings of about $2.52 per share in the third quarter, compared to forecasts for $2.65 per share, according to consensus estimates on FactSet. It expects revenue of around $3.10 billion, less than the $3.16 billion estimate. In a statement, CEO Vincent Roche said, “Looking to the second half, we expect revenue to moderate given the continued economic uncertainty and normalizing supply chains.”

First Horizon — The regional bank added 2.3% in premarket trading following an upgrade to buy from hold by Jefferies. The firm said the bank has top-tier capital strength and is at a discount to peers.

Palo Alto Networks — Shares of the cybersecurity rose nearly 5% in premarket trading after Palo Alto Networks reported a fiscal third quarter that topped analyst estimates. The company reported $1.10 in adjusted earnings per share on $1.72 billion of revenue. Analysts surveyed by Refinitiv had penciled in 93 cents of earnings per share on $1.71 billion of revenue. Palo Alto’s fourth-quarter earnings guidance was also higher than expected.

Kohl’s — The retailer popped more than 13% after reporting better-than-expected results and a surprise profit for the recent quarter. Kohl’s also reiterated previous guidance.

Intuit – The tax and accounting technology maker suffered a 5% drop after the company missed revenue expectations, according to Refinitiv, for its fiscal third quarter. That result was thanks in part to a decline in tax returns, Intuit reported.

— CNBC’s Jesse Pound, Samantha Subin, Alex Harring, Sarah Min and Tanaya Macheel contributed reporting

You might also like

China exports growth in March misses estimates, imports surge most in over four years

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

[ad_2]

Source link

Share30Tweet19
Previous Post

15 Important data terms you should know

Next Post

Sarepta says FDA is working toward accelerated approval of its latest treatment for Duchenne muscular dystrophy

Garry Wills

Garry Wills

Recommended For You

China exports growth in March misses estimates, imports surge most in over four years
Business Finance

China exports growth in March misses estimates, imports surge most in over four years

April 14, 2026
Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more
Business Finance

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

April 13, 2026
Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects
Business Finance

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

April 13, 2026
Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions
Business Finance

Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions

April 12, 2026
Next Post
Sarepta says FDA is working toward accelerated approval of its latest treatment for Duchenne muscular dystrophy

Sarepta says FDA is working toward accelerated approval of its latest treatment for Duchenne muscular dystrophy

Related News

Celtic outlast Rangers in Old Firm thriller to take major title step

Celtic outlast Rangers in Old Firm thriller to take major title step

April 8, 2023
NFT market cap drops by .2B as Ether rally loses steam

NFT market cap drops by $1.2B as Ether rally loses steam

August 18, 2025
Al Ahly vs Inter Miami: Prediction, kick-off time, team news, TV, odds

Al Ahly vs Inter Miami: Prediction, kick-off time, team news, TV, odds

June 14, 2025

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?